Format
Sort by

Send to

Choose Destination

Search results

Items: 9

1.

Proteome analysis of the Mycobacterium tuberculosis Beijing B0/W148 cluster.

Bespyatykh J, Shitikov E, Butenko I, Altukhov I, Alexeev D, Mokrousov I, Dogonadze M, Zhuravlev V, Yablonsky P, Ilina E, Govorun V.

Sci Rep. 2016 Jun 30;6:28985. doi: 10.1038/srep28985.

2.

Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology.

Chernyaeva EN, Shulgina MV, Rotkevich MS, Dobrynin PV, Simonov SA, Shitikov EA, Ischenko DS, Karpova IY, Kostryukova ES, Ilina EN, Govorun VM, Zhuravlev VY, Manicheva OA, Yablonsky PK, Isaeva YD, Nosova EY, Mokrousov IV, Vyazovaya AA, Narvskaya OV, Lapidus AL, O'Brien SJ.

BMC Genomics. 2014 Apr 25;15:308. doi: 10.1186/1471-2164-15-308.

3.

Unusual large-scale chromosomal rearrangements in Mycobacterium tuberculosis Beijing B0/W148 cluster isolates.

Shitikov EA, Bespyatykh JA, Ischenko DS, Alexeev DG, Karpova IY, Kostryukova ES, Isaeva YD, Nosova EY, Mokrousov IV, Vyazovaya AA, Narvskaya OV, Vishnevsky BI, Otten TF, Zhuravlev VIu, Yablonsky PK, Ilina EN, Govorun VM.

PLoS One. 2014 Jan 8;9(1):e84971. doi: 10.1371/journal.pone.0084971. eCollection 2014. Erratum in: PLoS One. 2014;9(2):e91479. Zhuravlev, Valery Y [corrected to Zhuravlev, Viacheslav Iu].

4.

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.

Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators.

Lancet. 2012 Jan 14;379(9811):123-9. doi: 10.1016/S0140-6736(11)61505-5. Epub 2011 Nov 28.

PMID:
22130488
5.

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators.

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.

6.

Tight junction proteins contribute to barrier properties in human pleura.

Markov AG, Voronkova MA, Volgin GN, Yablonsky PK, Fromm M, Amasheh S.

Respir Physiol Neurobiol. 2011 Mar 15;175(3):331-5. doi: 10.1016/j.resp.2010.12.012. Epub 2010 Dec 25.

PMID:
21187167
7.

A dose finding study of weekly and every-3-week nab-Paclitaxel followed by carboplatin as first-line therapy in patients with advanced non-small cell lung cancer.

Socinski MA, Manikhas GM, Stroyakovsky DL, Makhson AN, Cheporov SV, Orlov SV, Yablonsky PK, Bhar P, Iglesias J.

J Thorac Oncol. 2010 Jun;5(6):852-61.

8.

Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase.

Sokolov AV, Pulina MO, Ageeva KV, Ayrapetov MI, Berlov MN, Volgin GN, Markov AG, Yablonsky PK, Kolodkin NI, Zakharova ET, Vasilyev VB.

Biochemistry (Mosc). 2007 Apr;72(4):409-15.

PMID:
17511605
9.

One-stage allotransplantation of thoracic segment of the trachea in a patient with idiopathic fibrosing mediastinitis and marked tracheal stenosis.

Levashov YuN, Yablonsky PK, Cherny SM, Orlov SV, Shafirovsky BB, Kuznetzov IM.

Eur J Cardiothorac Surg. 1993;7(7):383-6.

PMID:
8373623
Items per page

Supplemental Content

Loading ...
Write to the Help Desk